Implementation Guidelines - Federal Transit Administration - U.S. ...
Implementation Guidelines - Federal Transit Administration - U.S. ... Implementation Guidelines - Federal Transit Administration - U.S. ...
Stand-Down Waivers The term “stand-down” refers to an employer practice of temporarily removing an employee from the performance of safety-sensitive duties after learning that the individual had a confirmed laboratory positive drug test, but before the MRO has completed the verification process. Historically, stand-downs have been prohibited under the DOT regulation, and they continue to be so under the new rule. MROs are not permitted to inform employers of a laboratory positive test until the MRO has determined if there is a legitimate medical explanation for the test result and has verified the test as either positive or negative. This prohibition is based on the premise that standing-down an employee before the MRO verification process is complete is premature, and could undercut the rationale for the MRO review. It could compromise confidentiality, and may unfairly stigmatize the employee as a drug user. Recognizing, however, that some employers advocate stand-downs to enhance safety and reduce liability, the new DOT rule (§40.21) includes a mechanism for employers, on a case-bycase basis, to seek waivers if certain conditions are met. Specifically, the employer must have a well-founded standdown plan that effectively protects the interests of the employees including confidentiality, and the facts must represent a genuine and plausible safety concern. FTA anticipates that few transit employers will be able to meet the stringent requirements delineated in the waiver request process, and therefore, no policy or procedural change will result. Under the DOT rule, the prohibition of stand-downs is narrowly defined and associated with the notification of the employer of a positive laboratory test result without MRO verification. This provision does not impede an employer’s policies that require the removal of employees from safety-sensitive duties for any other reason not specifically addressed in the regulation. Removal from Duty Following a Post- Accident or Reasonable Suspicion Test Some transit employers have established a policy under their own authority that requires employees be removed from safetysensitive service pending drug and alcohol test results following accidents and reasonable suspicion determinations. This practice is not considered a stand-down under the DOT rule, as the “event” was the reason for the person being removed from duty, not the laboratory test result. In this case, the employer has no knowledge of the drug test result, only that a drug test was required. This practice is not prohibited by FTA, but is encouraged due to liability considerations. Removal of Employees From Duty While Awaiting Split Specimen Test Results Employers have also been confused by how the stand-down prohibition relates to the practice of removing employees from duty following a non-negative test result (i.e., positive, adulterated, substituted), while awaiting the split specimen test result. Once the MRO has completed the review process and verified a test as non-negative, the employer is required to immediately remove the employee from safety-sensitive duties. The employee’s removal cannot be delayed while awaiting the split specimen result. Thus, this is not a stand-down as defined in the DOT rule as the laboratory test result has already been verified by the Chapter 4. Policy Development and Communication 4-6 August 2002
MRO before the employer is notified of the test result. Second Chance versus Zero Tolerance Once the FTA minimum consequences are met for a non-negative test result, FTA holds no position on the discipline that employers establish for test refusals, positive test results, adulterated or substituted specimens. Some employers practice zero-tolerance and discharge any employee who has a non-negative test result. Others operate under a second chance policy that allows employees who violated the rule to return to a safetysensitive position after successfully completing the return-to-duty process. Still others establish some hybrid policies based on past practice, employer philosophy, and labor/management agreements. Employers must reflect the employee consequences within the policy and clearly identify each as being provided under the employer’s own authority. This decision has far reaching implications and must be well thought out. There is no best or recommended disciplinary policy. Americans with Disabilities Act and Drug-Free Workplace Act Provisions If you develop a policy that includes components of the Drug-Free Workplace Act and the Americans with Disabilities Act (ADA), you should review Chapter 13, “Drug-Free Workplace Act of 1988,” and Appendix C, “Americans with Disabilities Act Discussion.” Section 3. POLICY ADOPTION A final review of the draft policy and/or policy revisions should be conducted by your legal representative and by your labor relations or personnel officer. This legal review is to ensure that there are no conflicts between the policy provisions, the FTA requirements, and other state and local laws. (Note: The FTA rule preempts contrary state and/or local laws.) The labor relations/personnel review should identify and resolve any conflicts between the policy and existing labor agreements or personnel policies. The requirements of the FTA regulations are not subject to bargaining. You should allocate sufficient time for this review and approval, and you should notify your governing board in the early stages of the policy development process that its approval will be required. The local governing board of the employer must officially adopt the policy and any substantive revisions made thereto. The governing board of the employer may take many forms depending on the organizational structure and legal formation of the agency. A list of the most common governing boards is provided on the following page. Chapter 4. Policy Development and Communication 4-7 August 2002
- Page 11 and 12: Chapter 1. INTRODUCTION Section 1.
- Page 13 and 14: Transit employers may go beyond the
- Page 15 and 16: Recommendation: Know the Regulation
- Page 17 and 18: Sample Documentation Chapter 1. Int
- Page 19 and 20: DHHS-Certified Laboratories, Center
- Page 21 and 22: FTA Drug and Alcohol Management Inf
- Page 23 and 24: Research And Special Programs Admin
- Page 25 and 26: employment in safety-sensitive posi
- Page 27 and 28: What happens in these cases? The pu
- Page 29 and 30: Section 3. SAFETY-SENSITIVE • Ope
- Page 31 and 32: performing the volunteer service ar
- Page 33 and 34: Safety-sensitive Examples of Nation
- Page 35 and 36: • A description of the consequenc
- Page 37 and 38: projects, the employer should notif
- Page 39 and 40: Sample Documentation Chapter 2. Reg
- Page 41 and 42: Certification of Compliance for FTA
- Page 43 and 44: 4. Atlanta Federal Center Suite 17T
- Page 45 and 46: 1. Liability of Service Agents Yasu
- Page 47 and 48: plaintiffs agreed that their positi
- Page 49 and 50: FTA and FMCSA Regulatory Comparison
- Page 51 and 52: FTA and FMCSA Regulatory Comparison
- Page 53 and 54: process ensures that all critical c
- Page 55 and 56: Chapter 3. Program Formulation 3-4
- Page 57 and 58: Chapter 4. POLICY DEVELOPMENT AND C
- Page 59 and 60: concentration of 0.04 or greater th
- Page 61: has a confirmed alcohol concentrati
- Page 65 and 66: policy with the requirement to form
- Page 67 and 68: Do not assume that your contractors
- Page 69 and 70: PRE-EMPLOYMENT DRUG TESTING NOTIFIC
- Page 71 and 72: Sample Program Notification Letter
- Page 73 and 74: authorized by the employer to make
- Page 75 and 76: The 60 minutes of awareness trainin
- Page 77 and 78: medications which could result in p
- Page 79 and 80: employees who have problems with pr
- Page 81 and 82: particular alcohol testing device t
- Page 83 and 84: emain current with the regulations
- Page 85 and 86: − Changes in Rules, Guidance and
- Page 87 and 88: Exhibit 5-1 Summary of Education an
- Page 89 and 90: Exhibit 5-3 Typical Agenda for Supe
- Page 91 and 92: Exhibit 5-4 REASONABLE SUSPICION TR
- Page 93 and 94: Chapter 6. TYPES OF TESTING Six typ
- Page 95 and 96: Previous DOT Employer Record Check
- Page 97 and 98: the “insufficient volume” proce
- Page 99 and 100: for employees what is meant by on-d
- Page 101 and 102: Nonfatal accidents involving a bus,
- Page 103 and 104: Testing for drugs and alcohol follo
- Page 105 and 106: iases in the process. To be conside
- Page 107 and 108: 1. Determine how frequently random
- Page 109 and 110: In many small transit systems, ever
- Page 111 and 112: Before making the return-to-duty re
Stand-Down Waivers<br />
The term “stand-down” refers to an<br />
employer practice of temporarily<br />
removing an employee from the<br />
performance of safety-sensitive duties<br />
after learning that the individual had a<br />
confirmed laboratory positive drug test,<br />
but before the MRO has completed the<br />
verification process.<br />
Historically, stand-downs have been<br />
prohibited under the DOT regulation, and<br />
they continue to be so under the new rule.<br />
MROs are not permitted to inform<br />
employers of a laboratory positive test<br />
until the MRO has determined if there is a<br />
legitimate medical explanation for the test<br />
result and has verified the test as either<br />
positive or negative. This prohibition is<br />
based on the premise that standing-down<br />
an employee before the MRO verification<br />
process is complete is premature, and<br />
could undercut the rationale for the MRO<br />
review. It could compromise<br />
confidentiality, and may unfairly<br />
stigmatize the employee as a drug user.<br />
Recognizing, however, that some<br />
employers advocate stand-downs to<br />
enhance safety and reduce liability, the<br />
new DOT rule (§40.21) includes a<br />
mechanism for employers, on a case-bycase<br />
basis, to seek waivers if certain<br />
conditions are met. Specifically, the<br />
employer must have a well-founded standdown<br />
plan that effectively protects the<br />
interests of the employees including<br />
confidentiality, and the facts must<br />
represent a genuine and plausible safety<br />
concern.<br />
FTA anticipates that few transit<br />
employers will be able to meet the<br />
stringent requirements delineated in the<br />
waiver request process, and therefore, no<br />
policy or procedural change will result.<br />
Under the DOT rule, the prohibition of<br />
stand-downs is narrowly defined and<br />
associated with the notification of the<br />
employer of a positive laboratory test result<br />
without MRO verification. This provision<br />
does not impede an employer’s policies that<br />
require the removal of employees from<br />
safety-sensitive duties for any other reason<br />
not specifically addressed in the regulation.<br />
Removal from Duty Following a Post-<br />
Accident or Reasonable Suspicion Test<br />
Some transit employers have established<br />
a policy under their own authority that<br />
requires employees be removed from safetysensitive<br />
service pending drug and alcohol<br />
test results following accidents and<br />
reasonable suspicion determinations. This<br />
practice is not considered a stand-down<br />
under the DOT rule, as the “event” was the<br />
reason for the person being removed from<br />
duty, not the laboratory test result. In this<br />
case, the employer has no knowledge of the<br />
drug test result, only that a drug test was<br />
required. This practice is not prohibited by<br />
FTA, but is encouraged due to liability<br />
considerations.<br />
Removal of Employees From Duty While<br />
Awaiting Split Specimen Test Results<br />
Employers have also been confused by<br />
how the stand-down prohibition relates to<br />
the practice of removing employees from<br />
duty following a non-negative test result<br />
(i.e., positive, adulterated, substituted),<br />
while awaiting the split specimen test result.<br />
Once the MRO has completed the review<br />
process and verified a test as non-negative,<br />
the employer is required to immediately<br />
remove the employee from safety-sensitive<br />
duties. The employee’s removal cannot be<br />
delayed while awaiting the split specimen<br />
result. Thus, this is not a stand-down as<br />
defined in the DOT rule as the laboratory<br />
test result has already been verified by the<br />
Chapter 4. Policy Development and Communication 4-6 August 2002